ArticleActa neurochirurgica2026
Long-term outcomes and lessons learned from treating incidental cerebral aneurysms: a cohort study of 322 patients.
Article in Acta neurochirurgica, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo evaluate the long-term outcomes associated with treating incidental unruptured intracranial aneurysms (UIAs). MATERIALS AND
methodsThis retrospective single-center cohort study included 322 patients with 431 UIAs, of which 356 were treated between January 2011 and July 2020. Treatment modalities included coiling, coiling with stenting, clipping, flow diverter stents, and the Woven EndoBridge device. Outcomes were assessed in terms of serious adverse events, recurrence rates, and aneurysm occlusion status based on the modified Raymond-Roy classification (MRRC).
resultsThe mean patient age was 53.1 years, with a predominance of females (71%). Most aneurysms (95%) were located in the anterior circulation. Clinical and radiological follow-up continued through May 2024 with a mean follow-up of 48.1 months. The perioperative complication rate was 7.0%, with 1.4% of patients experiencing permanent disability at 90 days. Late complications (occurring more than 12 months post-treatment) included one fatal stent thrombosis and one fatal aneurysmal rupture. Additionally, one patient suffered a subarachnoid hemorrhage (SAH) due to a de novo aneurysm, and another bled from a known but untreated aneurysm. The annual non-aneurysmal mortality rate was 0.97%. Recanalization occurred in 20% of aneurysms treated with coils. Seven patients (2.2%) were lost to follow-up.
conclusionTreatment of UIAs may be associated with very late complications, including delayed rupture. Approximately 20% of aneurysms treated with coils recanalized, necessitating long-term imaging surveillance. Non-aneurysmal mortality in this population is also non-negligible. These findings highlight the need for long-term evaluation of UIA treatment outcomes, ideally over a minimum follow-up period of five years.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.